Skip to main content

Peer Review reports

From: The value of innovation: association between improvements in survival of advanced and metastatic non-small cell lung cancer and targeted and immunotherapy

Original Submission
30 Apr 2021 Submitted Original manuscript
6 May 2021 Reviewed Reviewer Report
19 May 2021 Reviewed Reviewer Report
8 Jul 2021 Author responded Author comments - Sreeram Ramagopalan
Resubmission - Version 2
8 Jul 2021 Submitted Manuscript version 2
13 Jul 2021 Reviewed Reviewer Report
21 Jul 2021 Author responded Author comments - Sreeram Ramagopalan
Resubmission - Version 3
21 Jul 2021 Submitted Manuscript version 3
Publishing
22 Jul 2021 Editorially accepted
15 Sep 2021 Article published 10.1186/s12916-021-02070-w

You can find further information about peer review here.

Back to article page